In addition it addresses the FDA’s communications Together with the applicant, the retention of documents that support the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer possession of the SE report to a fresh applicant and Digital submission of the SE report and